M. L. Hanski

1.3k total citations · 1 hit paper
12 papers, 1.1k citations indexed

About

M. L. Hanski is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, M. L. Hanski has authored 12 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Oncology. Recurrent topics in M. L. Hanski's work include Glycosylation and Glycoproteins Research (5 papers), Galectins and Cancer Biology (4 papers) and Pancreatic and Hepatic Oncology Research (2 papers). M. L. Hanski is often cited by papers focused on Glycosylation and Glycoproteins Research (5 papers), Galectins and Cancer Biology (4 papers) and Pancreatic and Hepatic Oncology Research (2 papers). M. L. Hanski collaborates with scholars based in Germany, United States and France. M. L. Hanski's co-authors include C. Hanski, E O Riecken, Alexei Gratchev, B. Mann, H. J. Buhr, Anja Siedow, Mary Pat Moyer, Mohammad Ilyas, Marcos Gelos and Walter F. Bodmer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

M. L. Hanski

9 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Target genes of β-catenin–T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas

1999 677 citations B. Mann, Marcos Gelos et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. L. Hanski Germany	8	867	269	173	142	135	12	1.1k
Piera Maggiora Italy	11	458 0.5×	308 1.1×	123 0.7×	142 1.0×	91 0.7×	16	893
Kandavel Shanmugam United States	13	629 0.7×	509 1.9×	195 1.1×	152 1.1×	106 0.8×	27	1.1k
Arezoo Astanehe Canada	14	622 0.7×	291 1.1×	85 0.5×	75 0.5×	110 0.8×	18	913
Georgina Berrozpe United States	14	491 0.6×	256 1.0×	79 0.5×	234 1.6×	89 0.7×	17	904
Ulrike Lacher Germany	10	631 0.7×	295 1.1×	79 0.5×	109 0.8×	131 1.0×	14	942
Sylvia Streit Germany	10	624 0.7×	370 1.4×	78 0.5×	112 0.8×	113 0.8×	12	954
Michael B. Dilling United States	8	876 1.0×	301 1.1×	156 0.9×	91 0.6×	52 0.4×	8	1.1k
Archontoula Stoffel United States	12	548 0.6×	259 1.0×	102 0.6×	91 0.6×	41 0.3×	15	826
Tsukasa Oyama Japan	16	814 0.9×	275 1.0×	91 0.5×	72 0.5×	288 2.1×	26	1.3k
Andrew Berchuck United States	10	560 0.6×	375 1.4×	249 1.4×	84 0.6×	53 0.4×	11	1.1k

Countries citing papers authored by M. L. Hanski

Since Specialization

Citations

This map shows the geographic impact of M. L. Hanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. L. Hanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. L. Hanski more than expected).

Fields of papers citing papers by M. L. Hanski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. L. Hanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. L. Hanski. The network helps show where M. L. Hanski may publish in the future.

Co-authorship network of co-authors of M. L. Hanski

This figure shows the co-authorship network connecting the top 25 collaborators of M. L. Hanski. A scholar is included among the top collaborators of M. L. Hanski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. L. Hanski. M. L. Hanski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Hanski, M. L., et al.. (2012). Proliferation rate but not mismatch repair affects the long-term response of colon carcinoma cells to 5FU treatment. Cancer Letters. 320(1). 56–64. 4 indexed citations

2.

Hanski, M. L., et al.. (2011). UDCA slows down intestinal cell proliferation by inducing high and sustained ERK phosphorylation. International Journal of Cancer. 130(12). 2771–2782. 20 indexed citations

3.

Subramanian, Subbaya, M. L. Hanski, Martin Zeitz, & C. Hanski. (2010). 885 High and persistent ERK phosphorylation induced by ursodeoxycholic acid inhibits proliferation of intestinal epithelial cells. European Journal of Cancer Supplements. 8(5). 223–224.

4.

Subramanian, Sandhya, Christoph Loddenkemper, M. L. Hanski, Martin Zeitz, & C. Hanski. (2009). 6120 Ursodeoxycholic acid inhibits proliferation of intestinal epithelial cells: role of EGF and ERK pathway. European Journal of Cancer Supplements. 7(2). 359–359.

5.

Subramanian, S., et al.. (2008). UDCA targets S-phase and suppresses CDK2 and cyclin A expression: effects on colon cancer cell proliferation. Zeitschrift für Gastroenterologie. 46(9). 1 indexed citations

6.

Siedow, Anja, Moshe Szyf, Alexei Gratchev, et al.. (2002). De novo Expression of the Muc2 Gene in Pancreas Carcinoma Cells Is Triggered by Promoter Demethylation. Tumor Biology. 23(1). 54–60. 23 indexed citations

7.

Mann, B., Alexei Gratchev, Christian Böhm, et al.. (1999). FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas. British Journal of Cancer. 79(7-8). 1262–1269. 67 indexed citations

8.

Mann, B., Marcos Gelos, Anja Siedow, et al.. (1999). Target genes of β-catenin–T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proceedings of the National Academy of Sciences. 96(4). 1603–1608. 677 indexed citations breakdown →

9.

Hanski, C., A. Schmitt‐Gräff, M. L. Hanski, et al.. (1997). Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary. The Journal of Pathology. 182(4). 385–391. 124 indexed citations

10.

Hanski, C., et al.. (1996). Fucosyltransferase III and sialyl-Lex expression correlate in cultured colon carcinoma cells but not in colon carcinoma tissue. Glycoconjugate Journal. 13(5). 727–733. 32 indexed citations

11.

Hanski, C., et al.. (1995). Characterization of the major sialyl-Lex-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer.. PubMed. 55(4). 928–33. 60 indexed citations

12.

Hanski, C., Klaus Drechsler, F G Hanisch, et al.. (1993). Altered glycosylation of the MUC-1 protein core contributes to the colon carcinoma-associated increase of mucin-bound sialyl-Lewis(x) expression.. PubMed. 53(17). 4082–8. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact